Clicky

AngioDynamics, Inc.(ANGO) News

Date Title
Jun 23 AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism
Jun 9 ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
Jun 9 Zacks Industry Outlook Penumbra, Integer and AngioDynamics
Jun 6 NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
Jun 6 3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
Jun 5 Here's Why You Should Add PacBio Stock to Your Portfolio Now
Jun 4 Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Jun 4 What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?
May 28 NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
May 28 Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
May 26 BioSig Stock Surges Following Share Exchange Deal With Streamex
May 23 Reasons to Retain TransMedics Stock in Your Portfolio for Now
May 22 AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech
May 14 Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
Mar 14 MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
Mar 10 AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
Feb 24 Several Insiders Invested In AngioDynamics Flagging Positive News
Jan 30 AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
Jan 25 With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
Jan 8 AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates